Author:
Kwan Julia M.,Reese Amy M.,Trafeli John P.
Reference12 articles.
1. The use of systemic immune moderators in dermatology: an update;Stern;Dermatol Clin,2005
2. Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept;Weinberg;J Drugs Dermatol,2005
3. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial;Gordon;JAMA,2003
4. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis;Lebwohl;N Engl J Med,2003
5. Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial;Leonardi;J Am Acad Dermatol,2005
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献